Cargando…
Photorefraction Screening Plus Atropine Treatment for Myopia is Cost-Effective: A Proof-of-Concept Markov Analysis
PURPOSE: The prevalence of myopia is increasing globally, putting individuals at risk of myopia-associated visual impairment. Low-dose atropine eye drops have been found to safely reduce the risk of progression from myopia to higher levels of myopia and pathological states. In New Zealand, school ch...
Autores principales: | Hong, Chuen Yen, Boyd, Matt, Wilson, Graham, Hong, Sheng Chiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205435/ https://www.ncbi.nlm.nih.gov/pubmed/35720738 http://dx.doi.org/10.2147/OPTH.S362342 |
Ejemplares similares
-
Overnight orthokeratology is comparable with atropine in controlling myopia
por: Lin, Hui-Ju, et al.
Publicado: (2014) -
Topical Atropine in the Control of Myopia
por: GALVIS, Virgilio, et al.
Publicado: (2016) -
Stereoacuity after photorefractive keratectomy in myopia
por: Zarei-Ghanavati, Siamak, et al.
Publicado: (2016) -
Biological Mechanisms of Atropine Control of Myopia
por: Upadhyay, Aradhana, et al.
Publicado: (2020) -
Transepithelial Photorefractive Keratectomy for Low to Moderate Myopia in Comparison with Conventional Photorefractive Keratectomy
por: Naderi, Mostafa, et al.
Publicado: (2016)